Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Genomics and breast cancer screening

Tyler, April L. RN (APRN Student)1

Section Editor(s): Wysocki, Kenneth PhD, FNP, FAANP; Seibert, Diane PhD, ARNP, FAAN, FAANP

Journal of the American Association of Nurse Practitioners: September 2019 - Volume 31 - Issue 9 - p 485–487
doi: 10.1097/JXX.0000000000000279
Unraveling the Genome

ABSTRACT Many women fear the risk of developing breast cancer, and some women have increased fear because of their family history. Thankfully, the study of genetics has brought forth tools to better identify women at risk. An understanding of genetics and cancer has led to genetic testing protocols which enable at-risk women to take preventative action through medication, surgery, and intensive screenings. These protocols not only have the potential to prevent cancer but also lead to early detection. Appropriate screening for women at risk for genetic breast cancer is essential for patient care. These screenings include specific risk assessment tests, genetic counseling, and genetic testing. To provide the best possible care for patients, providers must have a basic understanding of cancer, genetics, screening tests, genetic testing, and available prevention measures.

1Maryville University, St. Louis, Missouri

Correspondence: April L. Tyler, RN, Maryville University, St. Louis, MO 63141. E-mail:

Competing interests: The author reports no conflicts of interest, and hopes her experience will help others.

Received May 21, 2019

Received in revised form June 09, 2019

Accepted June 13, 2019

© 2019 American Association of Nurse Practitioners
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website